Jingxia Han

1.4k total citations
25 papers, 791 citations indexed

About

Jingxia Han is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jingxia Han has authored 25 papers receiving a total of 791 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Jingxia Han's work include MicroRNA in disease regulation (5 papers), Skin Protection and Aging (5 papers) and RNA Interference and Gene Delivery (4 papers). Jingxia Han is often cited by papers focused on MicroRNA in disease regulation (5 papers), Skin Protection and Aging (5 papers) and RNA Interference and Gene Delivery (4 papers). Jingxia Han collaborates with scholars based in China, Switzerland and Belgium. Jingxia Han's co-authors include Tao Sun, Huijuan Liu, Jing Meng, Cheng Yang, Honggang Zhou, Shuang Chen, Heng Zhang, Weilong Zhong, Yanrong Liu and Yue-Yang Lei and has published in prestigious journals such as Advanced Materials, ACS Nano and Cancer Research.

In The Last Decade

Jingxia Han

25 papers receiving 784 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jingxia Han China	12	556	289	122	83	71	25	791
Liang Jiang China	19	653 1.2×	355 1.2×	119 1.0×	77 0.9×	35 0.5×	79	1.1k
Lizhong Liu China	9	542 1.0×	267 0.9×	142 1.2×	80 1.0×	35 0.5×	15	850
Aoxue Wang China	12	384 0.7×	253 0.9×	83 0.7×	121 1.5×	59 0.8×	32	866
Liangliang Shen China	17	466 0.8×	125 0.4×	127 1.0×	79 1.0×	88 1.2×	49	781
Mengjie Wang China	16	468 0.8×	217 0.8×	68 0.6×	98 1.2×	50 0.7×	65	818
Jie Zhu China	18	555 1.0×	265 0.9×	159 1.3×	124 1.5×	38 0.5×	55	946
Shan Cheng China	18	377 0.7×	108 0.4×	109 0.9×	54 0.7×	68 1.0×	67	734
Xianyi Meng China	15	350 0.6×	215 0.7×	119 1.0×	208 2.5×	26 0.4×	22	769
Nsrein Ali Finland	10	285 0.5×	161 0.6×	70 0.6×	60 0.7×	51 0.7×	16	538

Countries citing papers authored by Jingxia Han

Since Specialization

Citations

This map shows the geographic impact of Jingxia Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingxia Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingxia Han more than expected).

Fields of papers citing papers by Jingxia Han

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingxia Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingxia Han. The network helps show where Jingxia Han may publish in the future.

Co-authorship network of co-authors of Jingxia Han

This figure shows the co-authorship network connecting the top 25 collaborators of Jingxia Han. A scholar is included among the top collaborators of Jingxia Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingxia Han. Jingxia Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Xiaoyan, Fan Yang, Zhi Chang, et al.. (2025). Glycated ECM Derived Carbon Dots Inhibit Tumor Vasculogenic Mimicry by Disrupting RAGE Nuclear Translocation and Its Interaction With HMGB1. Advanced Materials. 37(24). e2419540–e2419540. 1 indexed citations

Li, Zhiyang, Heng Zhang, Yinan Li, et al.. (2025). Rbfox3 Promotes Transformation of MDSC‐Like Tumor Cells to Shape Immunosuppressive Microenvironment. Advanced Science. 12(8). e2404585–e2404585. 2 indexed citations

Han, Jingxia, Xiaohui Hou, Xiaorui Wang, et al.. (2024). MSC microvesicles loaded G-quadruplex-enhanced circular single-stranded DNA-9 inhibits tumor growth by targeting MDSCs. Journal of Nanobiotechnology. 22(1). 237–237. 4 indexed citations

Chen, Caihong, Yang Chen, Heng Zhang, et al.. (2024). EGR3 Inhibits Tumor Progression by Inducing Schwann Cell‐Like Differentiation. Advanced Science. 11(34). e2400066–e2400066. 4 indexed citations

Zhang, Heng, Jingxia Han, Lei Zhang, et al.. (2023). HSF4/COIL complex‐dependent R‐loop mediates ultraviolet‐induced inflammatory skin injury. Clinical and Translational Medicine. 13(7). e1336–e1336. 3 indexed citations

Qiao, Kailiang, Jingxia Han, Haohao Zhang, et al.. (2023). Intratumor Mycoplasma promotes the initiation and progression of hepatocellular carcinoma. Cell Reports. 42(12). 113563–113563. 5 indexed citations

Li, Zhiyang, Heng Zhang, Jingxia Han, et al.. (2023). Live-cell imaging-based dynamic vascular formation assay for antivascular drug evaluation and screening. iScience. 26(5). 106721–106721. 4 indexed citations

Wang, Hongqi, et al.. (2023). Microbiota-derived imidazole propionate inhibits type 2 diabetic skin wound healing by targeting SPNS2-mediated S1P transport. iScience. 26(11). 108092–108092. 6 indexed citations

Han, Jingxia, Jing Jin, Ting Wu, et al.. (2023). Polydopamine-loaded prunetin nanomaterials activate DRD2 to reduce UV-induced inflammation by stabilizing and promoting Nrf2 nuclear translocation. Acta Biomaterialia. 169. 556–565. 7 indexed citations

10.

Liu, Huijuan, Jingxia Han, Ying Lv, et al.. (2023). Isorhamnetin and anti-PD-L1 antibody dual-functional mesoporous silica nanoparticles improve tumor immune microenvironment and inhibit YY1-mediated tumor progression. Journal of Nanobiotechnology. 21(1). 208–208. 26 indexed citations

11.

Li, Yinan, Xiu Huang, Jing Jin, et al.. (2023). Interaction of TAGLN and USP1 promotes ZEB1 ubiquitination degradation in UV-induced skin photoaging. Cell & Bioscience. 13(1). 80–80. 2 indexed citations

12.

Meng, Jing, Jingxia Han, Xiaorui Wang, et al.. (2023). Twist1-YY1-p300 complex promotes the malignant progression of HCC through activation of miR-9 by forming phase-separated condensates at super-enhancers and relieved by metformin. Pharmacological Research. 188. 106661–106661. 20 indexed citations

13.

Li, Yinan, Heng Zhang, Caihong Chen, et al.. (2022). Biomimetic Immunosuppressive Exosomes that Inhibit Cytokine Storms Contribute to the Alleviation of Sepsis. Advanced Materials. 34(19). e2108476–e2108476. 71 indexed citations

14.

Han, Jingxia, Ting Wu, Jing Jin, et al.. (2022). Exosome-like nanovesicles derived from Phellinus linteus inhibit Mical2 expression through cross-kingdom regulation and inhibit ultraviolet-induced skin aging. Journal of Nanobiotechnology. 20(1). 455–455. 70 indexed citations

15.

Zhang, Zhiyuan, Jing Jin, Jingxia Han, et al.. (2020). Salidroside can target both P4HB-mediated inflammation and melanogenesis of the skin. Theranostics. 10(24). 11110–11126. 43 indexed citations

16.

Meng, Jing, Xiaoyu Ai, Yue-Yang Lei, et al.. (2019). USP5 promotes epithelial-mesenchymal transition by stabilizing SLUG in hepatocellular carcinoma. Theranostics. 9(2). 573–587. 101 indexed citations

17.

Zhang, Heng, Weilong Zhong, Bo Sun, et al.. (2019). Targeted Drug-Loaded Chemical Probe Staining Assay to Predict Therapy Response and Function as an Independent Pathological Marker. iScience. 21. 549–561. 1 indexed citations

18.

Meng, Jing, Shuang Chen, Jingxia Han, et al.. (2018). Twist1 Regulates Vimentin through Cul2 Circular RNA to Promote EMT in Hepatocellular Carcinoma. Cancer Research. 78(15). 4150–4162. 260 indexed citations

19.

Meng, Jing, Shuang Chen, Jingxia Han, et al.. (2018). Derepression of co-silenced tumor suppressor genes by nanoparticle-loaded circular ssDNA reduces tumor malignancy. Science Translational Medicine. 10(442). 28 indexed citations

20.

Meng, Jing, Yanrong Liu, Jingxia Han, et al.. (2017). Hsp90β promoted endothelial cell-dependent tumor angiogenesis in hepatocellular carcinoma. Molecular Cancer. 16(1). 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact